Status:
RECRUITING
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
As one of the most common malignant tumors in women, the incidence of ovarian cancer is expected to increase year by year. Due to its lack of typical symptoms and effective screening methods, and the ...
Eligibility Criteria
Inclusion
- female, ≥18 years old;
- diagnosed as ovarian cancer by imaging and pathology;
- did not receive any anti-tumor drug treatment before surgery in the gynecology clinical department of the Sun Yat Sen Memorial Hospital of Sun Yat-Sen University;
- received ovarian cancer surgery and Follow-up treatment;
- Patients voluntarily participate in the research of this subject, have good compliance, and can complete the enrollment by the requirements of the trial;
- Sign informed consent and agree to the collection and use of their data.
Exclusion
- Patients who have received other anti-tumor treatments or received tumor surgery before enrollment;
- Patients with malignant tumors in other parts;
- Patients with uncontrollable neurological, psychiatric, or mental disorders;
- Poor compliance and inability to Cooperate and describe treatment responders.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05251883
Start Date
January 1 2022
End Date
December 1 2026
Last Update
May 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit
Guangzhou, Guangdong, China